JC: Epistaxis – The NoPAC trial – Does TXA work?
Is Tranexamic Acid a useful adjunct in the management of epistaxis
JC: Epistaxis – The NoPAC trial – Does TXA work? Read More
Is Tranexamic Acid a useful adjunct in the management of epistaxis
JC: Epistaxis – The NoPAC trial – Does TXA work? Read More
Our regular round up of the best of the blog and podcast from January 2021 with Iain and Simon. The links to the articles are below together with a link
Podcast – January 2021 Monthly Round Up Read More
Going into hospital as an emergency during the COVID-19 pandemic must be extremely scary for patients and their relatives. With no relatives allowed to visit and staff dressed in full
Am I going to die? Communicating COVID-19 test results and risk Read More
In arguably the most important therapeutic news of the pandemic since Dexamethasone, the RECOVERY trial investigators have revealed the initial results on the Tocilizumab arm of the trial showing a
JC: RECOVERY trial shows Tocilizumab effective for COVID19. St Emlyn’s Read More
Two cars with an average speed of 40 mph. Measuring speed Imagine you are flying down the highway in the car of your dreams, sunglasses on, the wind in your
New Clinical Standards for Emergency Care Read More
We see a lot of patients in the ED with a history of what sounds very much like a transient ischaemic event (TIA). By definition the patient will have had
JC: Canadian TIA risk score. St Emlyn’s Read More
Oxygen targets in critically ill/injured patients has been something we’ve talked about on the blog before. In general the evidence to date has suggested that the routine prescription of oxygen
Oxygen targets in critical care: The HOT-ICU trial. St Emlyn’s Read More
Ed – We are delighted to publish a guest post from a great friend of St Emlyn’s, Joke from Belgium. She is one of a number of superb Belgian emergency
Lead yourself (through the COVID-19 pandemic). St Emlyn’s with Joke Van kerkhoven Read More